ProQR Therapeutics N.V. Ordinary Shares
Follow $PRQR
One email when a member of Congress discloses a trade in it, with the official filing receipt linked.
Free. No account. Unsubscribe in one click.
Follow $PRQR by emailVeridion Score
BETALOW CONF · 4 of 6 factors measuredsnapshot unavailable for PRQR. Cause unavailable.
Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Why is PRQR moving today?
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics. Geographically, the company operates in United States.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
PRQR overview
Related filings and maps
Congress activity in PRQR
No receipt-qualified Congressional disclosure is present for PRQR in the cached public ledger.
PRQR contract awards, year to date.
Public federal awards linked to this ticker.
PRQR lobbying filings, year to date.
Registered lobbying filings matched to ProQR Therapeutics N.V. Ordinary Shares.